wherein R1=H, Me; R2=H; R3=CH2COOMe, CH(Me)COOMe, CH(Et)COOMe, CH(CH2CH2SMe)COOMe, CH2COOH, CH(Me)COOH, CH(Et)COOH, CH(CH2CH2SMe)COOH, CH2CH2CH2CH2CH(NH2)COOH, CH2CH2CH2CH(NH2)COOH; R2, R3=CH2CH2CH2CH(COOMe); R2, R3=CH2CH2CH2CH(COOH). The above compounds are administered parenterally in a dose of 0.5-90 mg/kg, particularly in a dose of 1-3 mg/kg 10-120 minutes before administering nonsteroidal anti-inflammatory agents (e.g. aspirin or indomethacin), particularly 30 minutes before administering the nonsteroidal anti-inflammatory agents (e.g. aspirin or indomethacin) that enables reducing an area of erosions and ulcers of the gastric mucosa by 2-4 times as compared to a reference group receiving the nonsteroidal anti-inflammatory agents and receiving no declared compounds. The above phenylthioacetamides are applicable for preventing and treating the gastric ulcer caused by administering the therapeutic agents containing the nonsteroidal anti-inflammatory preparations of salycylates and acetic acid derivatives. The areas of the ulcer formation caused by the action of the nonsteroidal anti-inflammatory agents of salycylates (e.g. aspirin-containing) and acetic acid derivatives (e.g. indomethacin-containing) decrease after administering the phenylthioacetamide derivatives in the mammalian gastric mucosa.;EFFECT: higher clinical effectiveness.;6 cl, 12 ex, 9 dwg"/>
公开/公告号RU2530615C1
专利类型
公开/公告日2014-10-10
原文格式PDF
申请/专利权人 FEDERALNOE GOSUDARSTVENNOE BJUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO PROFESSIONALNOGO OBRAZOVANIJA MOSKOVSKIJ GOSUDARSTVENNYJ UNIVERSITET IMENI M.V. LOMONOSOVA (MGU);KIEVSKIJ NATSIONALNYJ UNIVERSITET IMENI TARASA SHEVCHENKO;
申请/专利号RU20130122040
发明设计人 OSTAPCHENKO LJUDMILA IVANOVNA;KUDRJAVTSEV KONSTANTIN VIKTOROVICH;ZEFIROV NIKOLAJ SERAFIMOVICH;FALALEEVA TATJANA MIKHAJLOVNA;BEREGOVAJA TATJANA VLADIMIROVNA;
申请日2013-05-14
分类号A61K31/16;A61P1/04;
国家 RU
入库时间 2022-08-21 15:38:19